ARTICLE SUMMARY:
Next-generation spinal cord stimulation was one of the new technologies highlighted at the recent annual meeting of the North American Spine Society, where smaller, focused spine companies were more visible than ever and top concerns included healthcare reform and evidence-based medicine.
This year’s annual meeting of the North American Spine Society (NASS) presented a smorgasbord of longstanding trends, including an ever-increasing emphasis on value-based medicine; the potential of disruptive technologies to drive growth of smaller, focused companies; and the slower growth of large companies, as they absorb mergers and management challenges.
